DE69637011D1 - Herstellung enzymatisch aktiver, rekombinanter carboxypeptidase b - Google Patents

Herstellung enzymatisch aktiver, rekombinanter carboxypeptidase b

Info

Publication number
DE69637011D1
DE69637011D1 DE69637011T DE69637011T DE69637011D1 DE 69637011 D1 DE69637011 D1 DE 69637011D1 DE 69637011 T DE69637011 T DE 69637011T DE 69637011 T DE69637011 T DE 69637011T DE 69637011 D1 DE69637011 D1 DE 69637011D1
Authority
DE
Germany
Prior art keywords
procpb
enzymatically active
preparation
active cpb
recombinant carboxypeptidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637011T
Other languages
English (en)
Other versions
DE69637011T2 (de
Inventor
Jacob Hartman
Netta Fulga
Simona Mendelovitch
Marian Gorecki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring International Center SA
Original Assignee
Ferring International Center SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring International Center SA filed Critical Ferring International Center SA
Publication of DE69637011D1 publication Critical patent/DE69637011D1/de
Application granted granted Critical
Publication of DE69637011T2 publication Critical patent/DE69637011T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69637011T 1995-01-25 1996-01-25 Herstellung enzymatisch aktiver, rekombinanter carboxypeptidase b Expired - Lifetime DE69637011T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37823395A 1995-01-25 1995-01-25
US378233 1995-01-25
PCT/US1996/000995 WO1996023064A1 (en) 1995-01-25 1996-01-25 Production of enzymatically active recombinant carboxypeptidase b

Publications (2)

Publication Number Publication Date
DE69637011D1 true DE69637011D1 (de) 2007-05-16
DE69637011T2 DE69637011T2 (de) 2007-12-13

Family

ID=23492292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637011T Expired - Lifetime DE69637011T2 (de) 1995-01-25 1996-01-25 Herstellung enzymatisch aktiver, rekombinanter carboxypeptidase b

Country Status (22)

Country Link
US (1) US5948668A (de)
EP (1) EP0871718B1 (de)
JP (1) JP4250716B2 (de)
KR (1) KR100566136B1 (de)
CN (1) CN1144874C (de)
AT (1) ATE358717T1 (de)
AU (1) AU698889B2 (de)
BR (1) BR9606795A (de)
CA (1) CA2210242C (de)
CZ (1) CZ292541B6 (de)
DE (1) DE69637011T2 (de)
DK (1) DK0871718T3 (de)
ES (1) ES2284167T3 (de)
HK (1) HK1014986A1 (de)
HU (1) HU225673B1 (de)
IL (1) IL116696A (de)
MX (1) MX9705279A (de)
NZ (1) NZ302874A (de)
PL (1) PL183228B1 (de)
PT (1) PT871718E (de)
WO (1) WO1996023064A1 (de)
ZA (1) ZA96515B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9610050A (pt) 1995-08-16 1999-10-13 Zeneca Ltd Conjugado,sitemas de dois componentes combinados destinados a uso em um hospedeiro, compostos ou um sal destes famaceuticamente aceitavel,enzima,sequencia de polinucleotìdeos e de02 nucleotìdeos,vetor, célula hospedeira,processos de producão de uma enzima e de um conjugado e de tratamento de célulasneoplásticas em um hospedeiro,composicão farmaceutica e plasmìdeo
CN102161984B (zh) 1998-08-06 2016-06-01 山景药品公司 分离四聚体尿酸氧化酶的方法
US20040117863A1 (en) * 1998-09-18 2004-06-17 Edge Michael D. Transgenically produced fusion proteins
DE19915938A1 (de) 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
WO2001019846A1 (en) * 1999-09-17 2001-03-22 Genzyme Transgenics Corporation Transgenically produced fusion proteins
EP1632575B1 (de) * 1999-09-29 2009-01-28 Lexicon Pharmaceuticals, Inc. Humane Carboxypeptidasen und diese kodierende Polynukleotide
EP1220932B1 (de) 1999-09-29 2005-11-09 Lexicon Genetics Incorporated Humane carboxypeptidasen und diese kodierende polynukleotide
AU2001229253A1 (en) * 2000-01-12 2001-07-24 Eli Lilly And Company Carboxypeptidase b free of animal products and contaminating enyzme activity
DE602004025192D1 (de) * 2003-12-05 2010-03-11 Roche Diagnostics Gmbh Rekombinante Carboxypeptidase B und ihre Aufreinigung
EP1538203B1 (de) * 2003-12-05 2010-01-20 Roche Diagnostics GmbH Rekombinante Carboxypeptidase B und ihre Aufreinigung
ATE517181T1 (de) * 2004-09-27 2011-08-15 Sanofi Aventis Deutschland Rekombinante carboxypeptidase b
WO2006110761A2 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. A variant form of urate oxidase and use thereof
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
HUE052976T2 (hu) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Urát-oxidáz variáns formái és azok alkalmazása
US20090081122A1 (en) * 2005-05-23 2009-03-26 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
PL2013225T3 (pl) 2006-04-12 2015-06-30 Crealta Pharmaceuticals Llc Oczyszczanie białek z zastosowaniem kationowego środka powierzchniowo czynnego
CN101058805B (zh) * 2007-03-21 2011-09-07 北京贯虹科技有限公司 突变羧肽酶原b及突变羧肽酶b的生产方法
US8993714B2 (en) * 2007-10-26 2015-03-31 Imiplex Llc Streptavidin macromolecular adaptor and complexes thereof
US9102526B2 (en) 2008-08-12 2015-08-11 Imiplex Llc Node polypeptides for nanostructure assembly
WO2010132363A1 (en) 2009-05-11 2010-11-18 Imiplex Llc Method of protein nanostructure fabrication
MX347903B (es) 2009-06-25 2017-05-18 Crealta Pharmaceuticals Llc Metodos y equipos para predecir el riesgo de reaccion a la infusion y perdida de respuesta mediada por anticuerpos al supervisar el acido urico en suero durante una terapia con uricasa conjugada con peg.
CN101967467B (zh) * 2009-07-28 2012-11-14 上海雅心生物技术有限公司 一种高稳定性的重组羧肽酶b的生产及应用
US11918624B2 (en) * 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK124483B (da) * 1967-12-04 1972-10-23 Bayer Ag Fremgangsmåde til rensning af carboxypeptidase B.
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
HU190129B (en) * 1983-07-11 1986-08-28 Reanal Finomvegyszergyar,Hu Process for the isolation of carboxypeptidase b enzyme from mammal pancreas
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
FR2692907B1 (fr) * 1992-06-25 1995-06-30 Rhone Poulenc Rorer Sa Levures kluyveromyces modifiees, preparation et utilisation.
JP3472587B2 (ja) * 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
CA2175834A1 (en) * 1993-11-16 1995-05-26 Jeffrey Tobin Fayerman Dna sequences encoding porcine pancreatic carboxypeptidase b

Also Published As

Publication number Publication date
PL321499A1 (en) 1997-12-08
ATE358717T1 (de) 2007-04-15
IL116696A0 (en) 1996-05-14
ES2284167T3 (es) 2007-11-01
WO1996023064A1 (en) 1996-08-01
ZA96515B (en) 1996-08-15
CA2210242A1 (en) 1996-08-01
DK0871718T3 (da) 2007-07-02
AU698889B2 (en) 1998-11-12
EP0871718A1 (de) 1998-10-21
EP0871718B1 (de) 2007-04-04
HUP9800091A2 (hu) 1998-05-28
BR9606795A (pt) 1997-12-30
IL116696A (en) 1999-08-17
HK1014986A1 (en) 1999-10-08
JP4250716B2 (ja) 2009-04-08
CA2210242C (en) 2010-04-27
CN1177377A (zh) 1998-03-25
NZ302874A (en) 1998-11-25
MX9705279A (es) 1998-06-30
PL183228B1 (pl) 2002-06-28
HUP9800091A3 (en) 2004-03-29
KR19980701652A (ko) 1998-06-25
JPH11503002A (ja) 1999-03-23
CZ225897A3 (cs) 1998-10-14
EP0871718A4 (de) 2000-06-07
DE69637011T2 (de) 2007-12-13
CN1144874C (zh) 2004-04-07
KR100566136B1 (ko) 2006-11-10
AU4903496A (en) 1996-08-14
US5948668A (en) 1999-09-07
PT871718E (pt) 2007-06-26
CZ292541B6 (cs) 2003-10-15
HU225673B1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
DE69637011D1 (de) Herstellung enzymatisch aktiver, rekombinanter carboxypeptidase b
NL300310I1 (nl) Productie van capsideneiwit en virusachtige deeltjes van mensenlijk papillomavirus
FI102962B1 (fi) Menetelmä ksylitolin valmistamiseksi
ATE326476T1 (de) Verfahren zur herstellung von phosphorothioat- oligomeren
ATE552891T1 (de) Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung
DE69939268D1 (de) Methoden zur aufreinigung von rekombinatem humanem erythropoietin aus zellkulturüberständen
FI963093A0 (fi) Bakteriosiini
ATE196458T1 (de) Verfahren zur herstellung von xylitol
DE3789309T2 (de) Enzymatische membran, verfahren zur herstellung und trennung von peptiden.
ATE240924T1 (de) Verfahren zur herstellung von methylmercatopropanal
HUP0001837A2 (hu) Új DNS és eljárás az új DNS által kódolt protein előállítására
MY119738A (en) Process for the purification of an alkanolamine
WO1999016883A3 (en) STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN
EP0733711A3 (de) Methode zur Klonierung und Herstellung einer SacI Restriktionsendonuklease
IT1275909B1 (it) Frammento di dna codificante d-amminoacido ossidasi
DE69706542T2 (de) Verfahren zur herstellung von xylitol
WO1998023762A3 (en) Methods of producing a recombinant protein
SE9503379D0 (sv) A modified GAD, a method for producing a modified GAD, a method for supplying a modified GAD, a peptide and the use of an ordinary and/or a modified GAD
WO1997016457A3 (de) Protein mit anti-tumorwirkung
EP0780398A3 (de) Verfahren zur Reinigung von Tamm-Horsfall-Glykoprotein und Uromodulin, die gereinigten Produkte und ein Verfahren für die Unterscheidung beider Stoffe
HUP9903854A2 (hu) Eljárás rekombináns humán interleukin-8 tisztítására
MX9603672A (es) Proceso para la produccion de una ciclosporina.
WO1998044103A3 (de) Protein zur inhibierung von apoptose
KR960029461A (ko) 재조합 미생물을 이용한 δ^5-3-케토스테로이드 이성화효소의 제조방법
MX9701267A (es) Receptor de glutamato.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition